"Advanced Pneumoconiosis Screening and Diagnosis" #sciencefather #invent...

Comments

Post a Comment

Popular posts from this blog

Wearable assistive device called ‘Blind Eye’ invented by Adilabad techie wins international award

Image
  Wearable assistive device called ‘Blind Eye’ invented by Adilabad techie wins international award Blind Eye, a revolutionary wearable assistive device invented by Tagire Ravi Kiran, an engineering student from the town and the founder of Allien Innovations, was exhibited at Global Incubation Week, held by UNICEF at Istanbul in Turkey from August 24 to 30. The device is meant for visually challenged persons. The son of a TGSRTC Adilabad depot clerk, Ravi was the first and only innovator from India to get an invitation by UNICEF to display his invention in the Global Incubation Week for winning the imaGen Venture award. He was one of the 10 innovators chosen from across the world to showcase thought-provoking yet useful solutions in the event. Kiran is going to receive a cash prize of Rs 8.5 lakh under imaGen Ventures award and will also be allowed to trial his device in 10 countries. Imagen Ventures award is constituted by Generation Unlimited, a leading global Public-Private-Y...
Read more

Synthetic biology, once hailed as a moneymaker, meets tough times

Image
It’s been a rough go lately for synthetic biology’s flagship companies, which genetically engineer microbes to produce everything from medicines to materials . Three highfliers—each of which once had multibillion-dollar market capitalizations—have fallen fast and hard. Amyris declared bankruptcy last year and by the beginning of this year had sold off several of its cosmetic and personal care product brands. In February, Zymergen, which was betting on microbes to produce transparent and flexible plastic films , liquidated its assets. And in June, Ginkgo Bioworks announced plans to lay off more than one-third of its workers after its stock tanked and revenues for its designer microbes failed to materialize. “There has been a reckoning,” says Jay Keasling, a synthetic biologist at Lawrence Berkeley National Laboratory and co-founder of Amyris. Still, not all synbio companies are generating bad news, with some focused on pharmaceuticals and additives living up to the hype that has of...
Read more

Obesity-drug pioneers win prestigious Lasker Award for medical science

Image
  Joel Habener (from left), Svetlana Mojsov and Lotte Bjerre Knudsen have won a 2024 Lasker Award for developing a class of drugs that treats obesity, diabetes and more. Three scientists involved in developing the blockbuster anti-obesity drugs that are currently changing the health-care landscape are among the winners of this year’s prestigious Lasker Awards. The prizes, which honour important advances in medical research, are often considered an indicator of whether a specific advance or scientist will win a Nobel Prize — and some are speculating that this could soon be the case for the weight-loss treatments. Joel Habener, Svetlana Mojsov and Lotte Bjerre Knudsen each contributed to the creation of the popular anti-obesity drugs, which mimic a hormone called glucagon-like peptide 1 (GLP-1), involved in lowering blood-sugar levels and controlling appetite. The trio, recognized with a Lasker in the clinical-research category, will share a US$250,000 prize. Biomedical scientists ...
Read more